Update shared on 03 Nov 2025
Fair value Increased 2.16%Analysts have raised their price target for Archrock from $30.89 to $31.56, citing updated outlooks on company performance and market conditions.
What's in the News
- Archrock completed the repurchase of 1,222,846 shares between July 1, 2025 and October 29, 2025. This brings the total shares bought back under the current plan to 3,942,161 for $79.7 million.
- On October 28, 2025, Archrock increased its equity buyback authorization by $100 million. This raised the total buyback program to $210.09 million and extended its duration to December 31, 2026.
- The company raised its earnings guidance for the full year 2025 and now expects net income between $265.2 million and $280.2 million.
Valuation Changes
- The Fair Value Estimate has increased moderately from $30.89 to $31.56.
- The Discount Rate has declined slightly from 8.82% to 8.61%.
- Revenue Growth expectations have decreased notably from 9.39% to 7.18%.
- Net Profit Margin projections have decreased slightly from 22.30% to 21.51%.
- The future P/E ratio has increased modestly from 17.90x to 18.56x.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.